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Abstract 
Objetive: Fibromyalgia (FM) is a chronic pain syndrome with unknown etiology, which affects predominantly 
women. Mitochondrial alteration could have a role in the pathophysilogical mechanisms of inflammatory condi-
tions as FM and periodontitis. The aim of the present study was assay the relationship between both diseases and 
mitochondrial dysfunction.
Patients and methods: We study the presence of periodontitis in twelve patients diagnosed of FM and mitochon-
drial dysfunction described. The diagnosis of FM was established according to ACR criteria and clinical symptoms 
were evaluated using the Fibromyalgia Impact Questionnaire (FIQ) and Beck Depression Inventory (BDI).
Results: Only one patients of twelve included and agreed to participate in the study were diagnosed with periodon-
titis.
Conclusions: Pending studies with larger numbers of patients, we can conclude that mitochondrial dysfunction 
in FM is a itself event not related with periodontitis. Periodontitis could be considered a exclusion criterion in all 
studies about mitochondrial dysfunction in patients. 
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Introduction
Fibromyalgia (FM) is a common chronic pain syndrome 
accompanied by other symptoms such as depression, 
anxiety, fatigue or sleep disturbances (1). The preva-
lence of FM in Spain is 2.4% in the general population, 
being significantly more frequent in females (4,2%) than 
in males (0,2%) (2). However, the pathogenic mecha-
nism of the disease is still unknown.
In recent years, new researches have shown evidence 
showing that mitochondrial dysfunction and oxidative 
stress may play an important role in the pathophysiology 
of FM (3,4). Oxidative stress, as an event characteristic 
of mitochondrial dysfunction is involved in other diseas-
es such as: atherosclerosis, hypertension, insulin resist-
ance, heart failure, and the aging process (5). Recently, it 
has also seen the presence of mitochondrial dysfunction 
and oxidative stress in patients with periodontitis (6). 
Periodontitis is a chronic infectious disease character-
ized by destructive inflammatory process affecting the 
tooth-supporting tissues resulting in loss of dentition. 
The cause is due to an ecological imbalance between 
the microbial biofilm on teeth and an impaired host in-
flammatory response. Oxidative stress is one of the main 
factors studied that could explain the pathophysiological 
mechanisms of inflammatory conditions that occur in 
the FM and periodontitis.
In order to demonstrate that mitochondrial dysfunction 
present in patients with FM is produced in the disease 
per se and not as a result of the presence of periodontitis, 
we propose in this paper the study of signs of periodon-
titis and the relationship with symptoms in a simple of 
patients with fibromyalgia. 
Patients and methods
We studied a sample of 20 patients of the Sevillian Fi-
bromyalgia Association (AFIBROSE) who met the cri-
teria of the American Collage of Rheumatology (ACR). 
Two were males and 18 females, with mean age of 
(SD) 50,8±8,6 years, with mean duration of disease of 
13,65±9,19 years and a mean of 14,9±3,1 tender points. 
The parameters of mitochondrial dysfunction in these pa-
tients were previously described in detail (4). Exclusion 
criteria were: rheumatic concomitant diseases, signifi-
cant systemic diseases (cardiopulmonary, neurological, 
renal or feverish), patients with severe psychopathology 
or psychoactive substance dependence and chronic pain 
patients of different origin to the FM. The study was per-
formed with the informed consent of all participants and 
the approval of the local ethical committee. Patients did 
not take any drugs or nutritional or vitamin supplements 
for a period of 15 days prior to sampling and reported a 
sedentary lifestyle. 
In patients, we evaluated the impact of the disease by 
testing the Spanish version of Fibromyalgia Impact 
Questionnaire (FIQ), with an interval of 0-80, pain by 
visual analog scale (VAS), with a range of 0-10, and 
depression using the standard version of the Beck De-
pression Inventory (BDI), with an interval of 0-63 (0-9 
no depression; 10-18 mild depression; 19-29 moderate 
depression; greater than 30 severe depression). 
A baseline periodontal examination was performed, and 
a single examiner collected full medical and dental his-
tories. A single trained dental examiner recorded peri-
odontal data. The periodontal probing depth (PD) and 
the recession of the gingival margin (GM) relative to the 
cementoenamel junction at six sites per tooth were re-
corded. Clinical attachment level (CAL) was calculated 
by adding recession to PD. PD and CAL were recorded 
to the nearest highest millimeter by means of the North 
Carolina periodontal probe (Hu-Friedy, Chicago, IL, 
USA), 15 mm in length and 0.35 mm in diameter. Ac-
cording to the criteria established by Machtei et al. (7), 
the clinical entity of periodontitis is based on the pres-
ence of CAL ≥ 6mm in two or more teeth and one or 
more sites with PD ≥ 5mm. Patients were divided into 
two groups: one with periodontitis (n = 1) and the other 
without periodontitis (n = 19). We also collected plaque 
and bleeding indices. The bleeding index of Van der 
Velden (8) was measured at six sites per tooth, while the 
plaque index of Silness and Löe (9) was valued at four 
sites per tooth.
Results
Patients showed high levels of pain determined by VAS, 
depression (BDI) and a high disease impact determined 
by the FIQ test (mean 7,2±2,2, 27±2,5 and 59,6±7,7, re-
spectively) characteristic of the disease (Table 1). With 
respect to periodontal disease, only 1 of 20 patients who 
met the inclusion criteria and agreed to participate in the 
study were diagnosed with periodontitis. Table 2 sum-
marizes the results of periodontal examination detailing 
of the parameters studied (GM, PD, CAL, dental plaque 
and bleeding on probing). As expected, the sample of 
patients with FM do not have periodontitis, with just one 
exception. 
PATIENTS RANGE
Age (years) 50,8 (8,6) _
Trigger points 14,9 (3,1) 0-18
Disease duration (years) 13,65 (9,19) _
Sex (female/male) 18/2 _
BMI (Kg/m2) 24,8 (2,1)  _
FIQ total score, range 0 80 59,6 (7,7) 0-80
VAS total score, range 0 10 7,2 (2,2) 0-10
BDI total score, range 0 63 27 (2,5) 0-63
BDI: Beck depression inventory; BMI: body mass index; FIQ: fibro-
mialgia impact questionnaire; VAS: visual analog scale. All values are 
mean (SD).
Table 1. Clinical characteristics of patients
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can say that mitochondrial dysfunction found in a sam-
ple of patients with fibromyalgia is characteristic of the 
disease and does not occur as a result of the presence of 
periodontal disease. 
On the other hand, another factor to consider in future 
research is that the presence of periodontitis should be 
considered as a exclusion criteria for any study whose 
objective the presence of mitochondrial dysfunction. 
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Discussion
In recent years, several studies have demonstrated the 
presence of markers of oxidative stress in FM, which 
raises the possibility of its involvement in the pathophy-
siology of the disease (3). Low levels of coenzyme Q 
have been detected (CoQ10) and an increased production 
of reactive oxygen species (ROS) in blood mononuclear 
cells of patients with FM, thus providing evidence of 
increased oxidative stress at the cellular level (10). On 
the other hand, oxidative stress and mitochondrial dys-
function are key factors that explain some of the patho-
physiological mechanisms associated with inflammatory 
conditions such as periodontitis, being lipid peroxidation 
one of its better known effects. In fact, there has been 
observed an increased lipid peroxidation in periodontitis 
(11), knowing that it indirectly reflects intracellular ROS 
production. Thus, it has also seen the presence of mito-
chondrial dysfunction in patients with periodontitis (6).
After excluding other diseases in which it is well recog-
nized the presence of mitochondrial dysfunction, in this 
article we propose the study of periodontal disease as 
another possible exclusion criteria in future studies that 
assess the presence of mitochondrial dysfunction and 
relate to the FM. To do this in this study we took into 
account several variables to determine whether mito-
chondrial dysfunction in patients with FM is due to the 
disease itself or whether it could be due to the presence 
of periodontitis. In our sample, we obtained as result the 
absence of periodontal disease,   this would confirm that 
mitochondrial disfunction present in patients with FM 
is typical of the disease and does not occur as a result 
of periodontitis. It is noteworthy that the patients inclu-
ded in the sample have high rates of dental plaque while 
bleeding on probing has very low values, this demostra-
tes the low susceptibility of the sample to both bleeding 
and thus periodontal disease. 
In conclusion, following the obtained results and wai-
ting for statistically superior studies in the sample, we 
Tabla 2. Results of periodontal examination.
PATIENTS MACHTEI CRITERIA
GM 0.12 ± 0.33
PD 1.65 ± 0.62 ≥ 5mm in 1 or 
more sites
CAL 1.75 ± 0.77 ≥ 6mm in 2 or 
more sites
Dental plaque 53.8 ± 3.2
Bleeding on probing 6.18 ± 4.3
The data represent means ± SD. GM, gingival margin; PD, probing 
depth; CAL, clinical attachment level. *p<0.001: statistically signifi-
cant difference.
